Resistance to Aspirin and/or Clopidogrel Among Patients With PAD.
Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
263 patients with peripheral atherosclerosis were examined to evaluate the activity of the
platelets during the standard treatment, including aspirin. A subgroup of 43 received 600 mg
of clopidogrel 2 h before platelet reactivity analysis.
The main hypothesis is that high platelet activity at the beginning of the study is
associated with a higher risk of atherothrombosis. Follow up time is 5 years.
Phase:
Phase 4
Details
Lead Sponsor:
Aalborg Universitetshospital Aalborg University Hospital